ASX - By Stock
|
PAR |
Re:
Ann: Successful Completion of Entitlement Offer
|
|
Leroy65
|
109 |
39K |
0 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
109
|
39K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful Completion of Entitlement Offer
|
|
Leroy65
|
109 |
39K |
7 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
109
|
39K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
PARate Day Share Price 2022
|
|
Leroy65
|
116 |
51K |
8 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
116
|
51K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
The Doctor Forum II - AF & FDA Round Table Discussion
|
|
Leroy65
|
29 |
12K |
8 |
10/09/22 |
10/09/22 |
ASX - By Stock
|
29
|
12K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
The Doctor Forum II - AF & FDA Round Table Discussion
|
|
Leroy65
|
29 |
12K |
12 |
09/09/22 |
09/09/22 |
ASX - By Stock
|
29
|
12K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
PAR stock price - what should today's value be?
|
|
Leroy65
|
36 |
17K |
3 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
36
|
17K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Leroy65
|
670 |
256K |
4 |
04/09/22 |
04/09/22 |
ASX - By Stock
|
670
|
256K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Leroy65
|
670 |
256K |
6 |
03/09/22 |
03/09/22 |
ASX - By Stock
|
670
|
256K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 2022 Annual Report and Appendix 4E
|
|
Leroy65
|
26 |
10K |
2 |
27/08/22 |
27/08/22 |
ASX - By Stock
|
26
|
10K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 2022 Annual Report and Appendix 4E
|
|
Leroy65
|
26 |
10K |
0 |
27/08/22 |
27/08/22 |
ASX - By Stock
|
26
|
10K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Doses First US Subjects under Phase 3 trial
|
|
Leroy65
|
58 |
24K |
4 |
21/08/22 |
21/08/22 |
ASX - By Stock
|
58
|
24K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Doses First US Subjects under Phase 3 trial
|
|
Leroy65
|
58 |
24K |
0 |
21/08/22 |
21/08/22 |
ASX - By Stock
|
58
|
24K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Doses First US Subjects under Phase 3 trial
|
|
Leroy65
|
58 |
24K |
5 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
58
|
24K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Doses First US Subjects under Phase 3 trial
|
|
Leroy65
|
58 |
24K |
2 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
58
|
24K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Doses First US Subjects under Phase 3 trial
|
|
Leroy65
|
58 |
24K |
10 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
58
|
24K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Leroy65
|
276 |
107K |
3 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
276
|
107K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm provides MPS Clinical Program update
|
|
Leroy65
|
9 |
6.3K |
12 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
9
|
6.3K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Partners with NFL Alumni Health for OA Program
|
|
Leroy65
|
63 |
20K |
5 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
63
|
20K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
'Something Cool is Coming'
|
|
Leroy65
|
22 |
9.6K |
3 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
22
|
9.6K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
PAR on Bell Potter list of stocks for FY 23
|
|
Leroy65
|
23 |
10K |
8 |
10/07/22 |
10/07/22 |
ASX - By Stock
|
23
|
10K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Reports Australian Patent Acceptance
|
|
Leroy65
|
64 |
24K |
4 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
64
|
24K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
The Heartfelt addressing...
|
|
Leroy65
|
10 |
5.0K |
4 |
20/06/22 |
20/06/22 |
ASX - By Stock
|
10
|
5.0K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Leroy65
|
4.2K |
3.8M |
12 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
12
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
4 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ampio -v- Zilosul
|
|
Leroy65
|
39 |
15K |
1 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
39
|
15K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
PARate Day Share Price 2022
|
|
Leroy65
|
116 |
51K |
1 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
116
|
51K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Doses First US Subjects under Phase 3 trial
|
|
Leroy65
|
58 |
24K |
12 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
58
|
24K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
3 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Pirate Day Share Price 2021
|
|
Leroy65
|
162 |
62K |
7 |
25/04/22 |
25/04/22 |
ASX - By Stock
|
162
|
62K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
8 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
8
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
10 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Ann: FDA Grants Paradigm Fast Track Designation For OA
|
|
Leroy65
|
88 |
42K |
11 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
88
|
42K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
PATENT REJECTED BUT PAR SILENT
|
|
Leroy65
|
12 |
6.4K |
2 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
12
|
6.4K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
8 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm patent rejection
|
|
Leroy65
|
87 |
29K |
6 |
06/03/22 |
06/03/22 |
ASX - By Stock
|
87
|
29K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Leroy65
|
4.2K |
3.8M |
1 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Leroy65
|
4.2K |
3.8M |
0 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Leroy65
|
339 |
138K |
3 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
339
|
138K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Leroy65
|
339 |
138K |
5 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
339
|
138K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Leroy65
|
339 |
138K |
0 |
02/01/22 |
02/01/22 |
ASX - By Stock
|
339
|
138K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Leroy65
|
339 |
138K |
0 |
02/01/22 |
02/01/22 |
ASX - By Stock
|
339
|
138K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Snoopy PI?
|
|
Leroy65
|
9 |
3.6K |
7 |
29/12/21 |
29/12/21 |
ASX - By Stock
|
9
|
3.6K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Leroy65
|
339 |
138K |
7 |
25/12/21 |
25/12/21 |
ASX - By Stock
|
339
|
138K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
PAR and the Deal, what do we need?
|
|
Leroy65
|
16 |
8.0K |
6 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
16
|
8.0K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
8 |
13/12/21 |
13/12/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
8
|
|
ASX - By Stock
|
PAR |
Re:
PAR Investor Meeting - Questions from HC
|
|
Leroy65
|
122 |
39K |
7 |
02/12/21 |
02/12/21 |
ASX - By Stock
|
122
|
39K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Leroy65
|
4.2K |
3.8M |
3 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Leroy65
|
339 |
138K |
9 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
339
|
138K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm CEO Paul Rennie to transition to Non-Exec Chairman
|
|
Leroy65
|
49 |
19K |
9 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
49
|
19K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
2 |
20/11/21 |
20/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
2
|
|